PCV1 DOES ROUTE OF ADMINISTRATION FOR ESTROGEN HORMONE THERAPY IMPACT RISK OF VENOUS THROMBOEMBOLISM- ESTRADIOL TRANSDERMAL SYSTEM VERSUS ORAL ESTROGEN-ONLY HORMONE THERAPY
Abstract
Authors
F. Laliberté K. Dea M.S. Duh K.H. Kahler M. Rolli P. Lefebvre